Pseudoprogression and hyperprogression secondary to immunotherapy in lung cancer

BACKGROUND: The treatment of non-small cell lung cancer (NSCLC) has undergone changes that have improved the prognosis of patients. With the advent of immunotherapy, it has been possible to prolong significantly the overall and progression-free survival as well as quality of life. Nevertheless, its...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	R. Riera-Sala, A. Ibarra-Morales, J. Guzmán-Casta, R. Medrano-Guzmán, A. Dip-Borunda, A. Martin-Aguilar, R. Grajales-Álvarez, R. Correa-Cano, K. Elvira-Fabián, C. Sánchez-Ríos, A. Orzuna-Vázquez, J. Rovelo-Lima, L. Martínez-Barrera, J. Rodríguez-Cid, J. Alatorre-Alexander
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Verduci Editore 2023-09-01
סדרה:	World Cancer Research Journal
נושאים:	pseudoprogression hyperprogression immunotherapy lung cancer
גישה מקוונת:	https://www.wcrj.net/wp-content/uploads/sites/5/2023/09/e2660.pdf
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!